Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Reduced Circulating Memory B-Cells Account for Humoral Immune Defects in Multiple Myeloma, Associated with Infective Risk and Poor Vaccination Responses

Jonathan Carmichael, MBBS, MRCP, Clive R Carter, Christopher Parrish, MD, Charlotte Kallmeyer, MDPhD, Sylvia Feyler, MDPhD, Philip M. Wood, FRCP, FRCPath, Gordon Cook, MD PhD

Blood (2014) 124 (21): 3393.

https://doi.org/10.1182/blood.V124.21.3393.3393

Published: 2014

Journal Articles

Treatment Patterns & Survival In Multiple Myeloma Patients Sequentially Exposed To Thalidomide, Bortezomib & Lenalidomide In a UK Single Centre

Julie L Tarant, MBChB MRCP(UK), John Ashcroft, MD, MBBChir, PhD, MRCP, MA, FRCPath, Sylvia Feyler, MD PhD, Roger G Owen, MD, Christopher Parrish, MA, MB, BChir, MRCP, Gordon Cook, MD, PhD

Blood (2013) 122 (21): 5380.

https://doi.org/10.1182/blood.V122.21.5380.5380

Published: 2013

Journal Articles

Lenalidomide Redresses the Effector T Cell:T reg Cell Imbalance in Patients with Multiple Myeloma.

Clive R Carter, Christopher Parrish, MD, Sylvia Feyler, MD PhD, Natuley Smalle, Gina B Scott, PhD, Charlotte Kallmeyer, MD PhD, Philip Wood, MD DPhil, Gordon Cook, MD PhD

Blood (2012) 120 (21): 2977.

https://doi.org/10.1182/blood.V120.21.2977.2977

Published: 2012

Journal Articles

Effect of combined dexamethasone/lenalidomide therapy on NK cell–receptor levels in myeloma patients

Clive R. Carter, Sylvia Feyler, Natuley Smalle, Gina B. Scott, Christopher Parrish, Katherine Cullen, Charlotte Kallmeyer, Philip M. Wood, Gordon Cook

Blood (2011) 118 (24): 6465–6466.

https://doi.org/10.1182/blood-2011-08-372680

Published: 2011

Journal Articles

Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation

Gareth J. Morgan, Faith E. Davies, Walter M. Gregory, Nigel H. Russell, Sue E. Bell, Alexander J. Szubert, Nuria Navarro Coy, Gordon Cook, Sylvia Feyler, Jenny L. Byrne, Huw Roddie, Claudius Rudin, Mark T. Drayson, Roger G. Owen, Fiona M. Ross, Graham H. Jackson, J. Anthony Child, for the NCRI Haematological Oncology Study Group

Blood (2011) 118 (5): 1231–1238.

https://doi.org/10.1182/blood-2011-02-338665

Published: 2011

Includes: Supplemental data

Journal Articles

Feasibility and Efficacy of Administration of Bortezomib-Containing Regimens to Patients Over the Age of 70 Years

Christopher Parrish, MA, MB, BChir, MRCP, Julian Cromack, Sylvia Feyler, MD, MRCP, FRCPath, John Ashcroft, MD, MBBChir, PhD, MRCP, MA, FRCPath, Roger G. Owen, MD, Gordon Cook, MD

Blood (2010) 116 (21): 5035.

https://doi.org/10.1182/blood.V116.21.5035.5035

Published: 2010

Journal Articles

Multiple Myeloma Generates Regulatory T-Cells in a Contact-Dependent Manner Independent of TGF-Beta and IL-10.

Sylvia Feyler, MD, MRCP, FRCPath, Marie von Lilienfeld-Toal, Sarah J Jarmin, PhD, Paul Evans, Mike Short, Kate McKinley, Peter J Selby, Gordon Cook, MD, PhD

Blood (2009) 114 (22): 2835.

https://doi.org/10.1182/blood.V114.22.2835.2835

Published: 2009

Journal Articles

Reguatory T-Cell Subsets Demonstrate Quantitative Differences but Not Functional Abnormalities in Patients with Multiple Myeloma (MM) Compared with Healthy Controls.

Sylvia Feyler, MD, Marie von Lilienfeld-Toal, MD, Lee Marles, PhD, Andy Rawstron, PhD, Roger G. Owen, MD, John Ashcroft, PhD, Gordon Cook, PhD

Blood (2007) 110 (11): 3511.

https://doi.org/10.1182/blood.V110.11.3511.3511

Published: 2007

Journal Articles

Increased Regulatory T Cell Subsets (T Reg and Tr1 Cells) in the Peripheral Blood of Patients with Multiple Myeloma Correlate with Disease Stage.

Sylvia Feyler, MD, Lee Marles, PhD, Stevie Richards, PhD, Gordon Cook, MD, PhD

Blood (2005) 106 (11): 5070.

https://doi.org/10.1182/blood.V106.11.5070.5070

Published: 2005

Journal Articles

The Role of High Dose Therapy and Stem Cell Rescue in the Management of T-Cell Malignant Lymphomas (TCL): A BSBMT and ABMTRR Study.

Sylvia Feyler, MD, Miles Prince, MD, Rachel Pearce, PhD, Kieren Towlson, Ian Nivison-Smith, David I. Marks, MD, Gordon Cook, MD, PhD

Blood (2005) 106 (11): 678.

https://doi.org/10.1182/blood.V106.11.678.678

Published: 2005

Journal Articles

Thalidomide Maintenance Following High Dose Therapy in Multiple Myeloma: A UK Myeloma Forum Phase 2 Study.

Sylvia Feyler, MD, Andy Rawstron, PhD, Graham Jackson, MD, John Snowden, MD, Kim Hawkins, PhD, Roderick J. Johnson, MD

Blood (2005) 106 (11): 641.

https://doi.org/10.1182/blood.V106.11.641.641

Published: 2005

NARROW

Reduced Circulating Memory B-Cells Account for Humoral Immune Defects in Multiple Myeloma, Associated with Infective Risk and Poor Vaccination Responses

Treatment Patterns & Survival In Multiple Myeloma Patients Sequentially Exposed To Thalidomide, Bortezomib & Lenalidomide In a UK Single Centre

Lenalidomide Redresses the Effector T Cell:T reg Cell Imbalance in Patients with Multiple Myeloma.

Effect of combined dexamethasone/lenalidomide therapy on NK cell–receptor levels in myeloma patients

Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation

Feasibility and Efficacy of Administration of Bortezomib-Containing Regimens to Patients Over the Age of 70 Years

Multiple Myeloma Generates Regulatory T-Cells in a Contact-Dependent Manner Independent of TGF-Beta and IL-10.

Reguatory T-Cell Subsets Demonstrate Quantitative Differences but Not Functional Abnormalities in Patients with Multiple Myeloma (MM) Compared with Healthy Controls.

Increased Regulatory T Cell Subsets (T Reg and Tr1 Cells) in the Peripheral Blood of Patients with Multiple Myeloma Correlate with Disease Stage.

The Role of High Dose Therapy and Stem Cell Rescue in the Management of T-Cell Malignant Lymphomas (TCL): A BSBMT and ABMTRR Study.

Thalidomide Maintenance Following High Dose Therapy in Multiple Myeloma: A UK Myeloma Forum Phase 2 Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only